Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ADGI

Adagio Therapeutics (ADGI)

Adagio Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADGI
FechaHoraFuenteTítuloSímboloCompañía
29/06/202306:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
25/05/202317:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
12/04/202315:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202315:20Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202315:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202315:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADGIAdagio Therapeutics Inc
31/03/202315:38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADGIAdagio Therapeutics Inc
23/03/202315:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADGIAdagio Therapeutics Inc
09/02/202310:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADGIAdagio Therapeutics Inc
19/12/202206:00GlobeNewswire Inc.Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA WorkshopNASDAQ:ADGIAdagio Therapeutics Inc
06/12/202215:01GlobeNewswire Inc.Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical OfficerNASDAQ:ADGIAdagio Therapeutics Inc
29/11/202216:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADGIAdagio Therapeutics Inc
10/11/202215:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADGIAdagio Therapeutics Inc
06/10/202205:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADGIAdagio Therapeutics Inc
12/09/202206:15GlobeNewswire Inc.Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron VariantsNASDAQ:ADGIAdagio Therapeutics Inc
12/09/202206:00GlobeNewswire Inc.Adagio Therapeutics Announces Corporate Name Change to InvivydNASDAQ:ADGIAdagio Therapeutics Inc
06/09/202215:01GlobeNewswire Inc.Adagio Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:ADGIAdagio Therapeutics Inc
19/08/202216:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADGIAdagio Therapeutics Inc
15/08/202205:30GlobeNewswire Inc.Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:ADGIAdagio Therapeutics Inc
05/07/202207:00Business WireMithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy CampaignNASDAQ:ADGIAdagio Therapeutics Inc
05/07/202206:25GlobeNewswire Inc.Adagio Announces David Hering Named Permanent Chief Executive Officer and DirectorNASDAQ:ADGIAdagio Therapeutics Inc
01/07/202205:30GlobeNewswire Inc.Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of DirectorsNASDAQ:ADGIAdagio Therapeutics Inc
06/06/202205:03Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADGIAdagio Therapeutics Inc
02/06/202215:25Edgar (US Regulatory)Information Statement - Contested Solicitations (definitive) (defc14c)NASDAQ:ADGIAdagio Therapeutics Inc
19/05/202216:07Edgar (US Regulatory)Information Statement - Contested Solicitations (preliminary) (prec14c)NASDAQ:ADGIAdagio Therapeutics Inc
19/05/202215:31ValueWalkAdagio Therapeutics Jumps 629 Ranks To 119th Most Owned Stock On The PlatformNASDAQ:ADGIAdagio Therapeutics Inc
17/05/202207:45TipRanksAdagio Therapeutics (ADGI) Gets a Sell Rating from Morgan StanleyNASDAQ:ADGIAdagio Therapeutics Inc
13/05/202209:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADGIAdagio Therapeutics Inc
13/05/202205:30GlobeNewswire Inc.Adagio Therapeutics Reports First Quarter 2022 Financial ResultsNASDAQ:ADGIAdagio Therapeutics Inc
29/04/202216:22Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADGIAdagio Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ADGI